Access to screening, testing, treatment, and follow-up for IFNAR1 deficiency is likely to be inequitable across affected nations and communities, and we call upon well-resourced agencies and organizations to support the establishment of medical and public health infrastructures to enable affected Polynesian communities to benefit equitably from such measures. The gene discussed is IFNAR1; the disease is hyperinsulinemic hypoglycemia, familial, 4.